Announcements Trials
Browse Landscape

Phase

Phase 3 1

Status

Completed 1

Sponsor Class

INDUSTRY 1

Study Type

Interventional 1

Sponsor

Cancer Type

Gynecologic 1

Conditions

Papillomavirus Infections 4Uterine Cervical Neoplasms 3Hepatitis B 1

Interventions

entecavir 10Lamivudine 5Tenofovir 4lenvatinib 2Sorafenib 2Radiofrequency Ablation 2Hepatitis B Vaccines 2tenofovir alafenamide 1polysaccharide MGN3 1peginterferon alfa-2b 1peginterferon alfa-2a 1navitoclax 1menatetrenone 1lens intermediate filament proteins 1human papillomavirus vaccine, L1 type 16, 18 1hepatitis B hyperimmune globulin 1bicyclol 1adefovir dipivoxil 1adefovir 1Urinalysis 1Ultrasonography 1Tumor Necrosis Factor-alpha 1Tetanus Toxoid 1Telbivudine 1Tablets 1Standard of Care 1Rapid Diagnostic Tests 1Raltegravir Potassium 1Radiomics 1Practice Guidelines as Topic 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Hepatitis B × Engerix-B × Clear all
NCT00637195 2020-01-03

Immunogenicity and Safety of a Commercially Available Vaccine Co-administered With GSK HPV Vaccine (580299)

GlaxoSmithKline

Phase 3 Completed
152 enrolled 21 charts
Gynecologic

Uterine Cervical Neoplasms, Hepatitis B, Papillomavirus Infections

Data powered by HemOnc (CC BY 4.0) Colophon âš¡